Bart van Rhijn
Vermögen: 16 Mio $ am 31.07.2026
Vermögen: 16 Mio $ am 31.07.2026
Bart van Rhijn is currently Chief Financial & Business Officer at Nanobiotix SA since 2021.
Formerly, Mr. van Rhijn was Senior Director-Mergers & Acquisitions at Philips Research Laboratories from 2007 to 2010, Head-Finance at Galderma International SAS from 2015 to 2018, Chief Financial Officer at Servier Pharmaceuticals LLC from 2018 to 2021, and Head-Tax at PricewaterhouseCoopers Services BV.
Education includes a graduate degree from the University of Leiden and an MBA from Babson College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NANOBIOTIX SA 0,81 % | 31.03.2026 | 410.747 ( 0,81 % ) | 16 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NANOBIOTIX | Finanzdirektor/CFO | 01.06.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Finanzdirektor/CFO | 01.05.2021 |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Researches, develops and markets therapeutic and aesthetic solutions for dermatology | Corporate Officer/Principal | 01.08.2018 |
Philips Research Laboratories
Philips Research Laboratories Miscellaneous Commercial ServicesCommercial Services Operates as a research and development lab | Corporate Officer/Principal | 01.02.2010 |
PricewaterhouseCoopers Services BV
PricewaterhouseCoopers Services BV Information Technology ServicesTechnology Services Provides technology, cloud, audit and tax consulting services | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Researches, develops and markets therapeutic and aesthetic solutions for dermatology | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanobiotix SA
Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
PricewaterhouseCoopers Services BV
PricewaterhouseCoopers Services BV Information Technology ServicesTechnology Services Provides technology, cloud, audit and tax consulting services | Technology Services |
Philips Research Laboratories
Philips Research Laboratories Miscellaneous Commercial ServicesCommercial Services Operates as a research and development lab | Commercial Services |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen